Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga Real-time News ·  {{timeTz}}

Â

Gainers

  • Marker Therapeutics (NASDAQ:MRKR) shares increased by 54.3% to $0.51 during Friday's regular session. The current volume of 63.7 million shares is 16959.7% of Marker Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $42.5 million.
  • Athenex (NASDAQ:ATNX) stock moved upwards by 50.75% to $0.95. As of 13:30 EST, this security is trading at a volume of 11.1 million shares, making up 997.5% of its average full-day volume over the last 100 days. The company's market cap stands at $115.4 million.
  • Progyny (NASDAQ:PGNY) shares rose 40.24% to $41.75. Progyny's stock is trading at a volume of 2.3 million shares as of 13:30 EST. This is 297.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.8 billion. As per the press release, Q2 earnings came out yesterday.
  • Global Blood Therapeutics (NASDAQ:GBT) shares rose 36.77% to $65.64. As of 13:30 EST, this security is trading at a volume of 9.1 million shares, making up 553.1% of its average full-day volume over the last 100 days. The company's market cap stands at $4.2 billion.
  • GH Research (NASDAQ:GHRS) shares rose 27.28% to $15.49. The market value of their outstanding shares is at $805.8 million.
  • Selecta Biosciences (NASDAQ:SELB) stock moved upwards by 27.12% to $2.39. As of 13:30 EST, this security is trading at a volume of 5.1 million shares, making up 227.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $362.8 million. As per the press release, Q2 earnings came out yesterday.

Losers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock fell 58.0% to $5.91 during Friday's regular session. Trading volume for Quoin Pharmaceuticals's stock is 11.5 million as of 13:30 EST. This is 362.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million.
  • Health Catalyst (NASDAQ:HCAT) shares decreased by 36.29% to $11.64. Health Catalyst's stock is trading at a volume of 5.3 million shares as of 13:30 EST. This is 546.2% of its average full-day volume over the last 100 days. The company's market cap stands at $630.7 million. The company's, Q2 earnings came out yesterday.
  • Exagen (NASDAQ:XGN) stock declined by 22.72% to $6.42. Exagen's stock is trading at a volume of 60.7K shares as of 13:30 EST. This is 105.1% of its average full-day volume over the last 100 days. The company's market cap stands at $104.2 million. As per the news, the Q2 earnings report came out yesterday.
  • Heart Test Laboratories (NASDAQ:HSCS) shares decreased by 18.31% to $2.21. Trading volume for this security as of 13:30 EST is 712.3K, which is 61.4% of its average full-day volume over the last 100 days.
  • Cognition Therapeutics (NASDAQ:CGTX) stock declined by 15.56% to $3.04. As of 13:30 EST, Cognition Therapeutics's stock is trading at a volume of 1.7 million, which is 462.3% of its average full-day volume over the last 100 days. The company's market cap stands at $68.6 million.
  • Definitive Healthcare (NASDAQ:DH) stock fell 15.28% to $24.85. Trading volume for this security as of 13:30 EST is 1.3 million, which is 225.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.4 billion. As per the news, the Q2 earnings report came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal.


Moomoo is a financial information and trading app offered by Moomoo Techonologies Inc.


In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).


In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. ("Moomoo Financial SG") regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial SG is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.


In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.